The overarching aim of this study is to develop sensitive measures for aspects of social cognition that are crucial for the abilities to display adequate social-interpersonal behaviours, including traffic safety, as well as to develop better…
ID
Source
Brief title
Condition
- Neurological disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The overarching aim of this study is to develop sensitive measures for aspects
of social cognition that are crucial for the abilities to display adequate
social-interpersonal behaviours, including traffic safety, as well as to
develop better assessment procedures for unsafe, risk-taking behaviour
endangering other people. These measures will result in better measurement of
impairments in social cognition and behaviour, which will attribute to better
detection of SC problems in all (frontal) brain injury patients, and a more
timely diagnosis of these behavioural YOD subtypes. This will be done by
comparing patients with behavioural variants of YOD and frontal brain injury to
patients with non-behavioural variants of YOD and non-frontal brain-injury, and
to healthy controls on measures of social cognition and risk-taking behaviour.
This way, we can see if the newly developed measures are sensitive for frontal
brain pathology.
Secondary outcome
Subsequently, we will investigate validity of the new measurements by relating
it to other social cognitive and other cognitive measures. We will also assess
whether and how impairments in aspects of social cognition are related to
risk-taking behaviour to determine if the SC test are able to predict
risk-taking behaviour. Furthermore, the aim is to develop driving simulator
scenarios eliciting risk-taking behaviour in patients that can possibly be of
use in the judgement of fitness to drive of patients with YOD, but also in
other patient groups in which behavioural problems occur frequently, such as
patients with frontal brain injury. As a result of this study, we hope to aid
to the diagnosis of social behavioural symptoms and a timely identification of
unsafe risk-taking behaviour, in particular in traffic, in patients with YOD
and other neurological conditions affecting frontal functions.
Background summary
Young-onset Dementia (YOD) refers to dementia with the onset before the age of
65 years. A common type of YOD is frontotemporal dementia (FTD), but there can
also be young onset types of Alzheimer*s disease, as well as many other
different subtypes. Characteristic of YOD is that impairments in language,
perception or (social) behavioural changes are more prominent in the early
disease stages than memory impairments. These symptoms are often
under-recognized, which delays the diagnosis of YOD and consequently
contributes to a much more difficult situation for both patients and their
close others. An important affected domain in various subtypes of YOD, is
social cognition (SC). SC refers to the capacities that enable adequate social
behaviours and interactions and includes aspects such recognition of other
person*s emotional expressions, the ability to experience emotions, empathy and
perspective-taking or theory of mind (ToM). SC is underpinned by
frontal-subcortical networks, which are affected in specific subtypes of YOD.
In addition, impairments in social cognition are also frequent symptoms in
patients with neurological disorders which affect frontal-subcortical networks,
such as severe traumatic brain injury (TBI) or frontally located brain tumours.
Impairments in SC involve an inability to detect emotional signals that
indicate danger during decision-making, or to take other people*s feelings and
perspective into account. Hence, such impairments are frequently linked to
inadequate, inappropriate or even problematic social behaviour, so called
*behaviours of concern, which are potentially harmful to other people such as
aggression or unsafe driving.
At present there are only a few neuropsychological tests available that measure
aspects of SC, but to date, tests that reliably measure the abilities to have
empathy with others and to take their perspective, and to feel emotions and
take these into account in situations involving the safety of other people are
still lacking. Hence, there is a large unmet need for better neuropsychological
measures of social cognition that are sensitive to impairments in social
cognition, also allowing a more timely diagnosis of the specific subtypes of
YOD. Moreover, there is also a lack of assessment procedures that can reliably
identify patients that have a high risk to display unsafe behaviours, in
particular in traffic situations. An additional problem is that to determine
whether patients with early dementia are still safe to drive, the measure that
is used (the CDR score) relies heavily on the presence of memory problems.
Hence, YOD patients with intact memory but severe SC impairments might still be
considered fit to drive.
Study objective
The overarching aim of this study is to develop sensitive measures for aspects
of social cognition that are crucial for the abilities to display adequate
social-interpersonal behaviours, including traffic safety, as well as to
develop better assessment procedures for unsafe, risk-taking behaviour
endangering other people. These measures will result in better measurement of
impairments in social cognition and behaviour, which will attribute to a more
timely diagnosis of these behavioural YOD subtypes. Also, if we can establish
that the new tests for social cognition significantly relate to the
measurements of unsafe driving behaviour, these tests can also be used for
timely identification of patients at risk for displaying these unsafe
behaviours. And finally, having better assessment procedures for unsafe driving
behaviours will aid in deciding whether patients with early YOD but no memory
deficits and other neurological conditions affecting frontal functions are
still fit to drive. We will develop sensitive measures for different aspects of
social cognition (empathy, theory of mind, emotion experience) and for
risk-taking behaviour.
Study design
This study is designed as an observational and experimental case-control study.
Study burden and risks
There are no direct benefits for the patient. A potential risk is simulator
sickness (similar to car sickness) during the driving simulator test.
Participants are notified of this possibility beforehand and will be monitored
during the test. They will also be informed of their right to stop the test at
any time. A general risk is that assessments (neuropsychological assessment and
driving simulator assessment) can be too demanding for patients; however,
neuropsychologists carrying out the assessments are experienced in testing
vulnerable patients and will carefully monitor whether the assessments are too
demanding, and quit if necessary.
Hanzeplein 1
Groningen 9713GZ
NL
Hanzeplein 1
Groningen 9713GZ
NL
Listed location countries
Age
Inclusion criteria
All subjects
- Sufficient command of the Dutch language
- Any driving experience throughout life
- Age 18 to 70
bvYOD subjects
- Probable diagnosis of young-onset (before 65 years old) bvFTD according to
the current criteria (Rascovsky et al., 2011) or bvAD according to criteria
current criteria (McKhann et al., 2011), or another behavioural YOD subtype,
confirmed after interdisciplinary consensus meeting in which interviews,
neuropsychological examination, neurological and psychiatric assessments,
neuro-imaging, blood samples, and in some cases FDG/PIB-PETscans, CSF
biomarkers or genetic counselling were discussed.
Non-bvYOD subjects
- Probable diagnosis of young-onset dementia (before 65 years old) other than a
behavioural YOD subtype such as bvFTD or bvAD, for example amnestic variant AD,
confirmed after interdisciplinary consensus meeting in which interviews,
neuropsychological examination, neurological and psychiatric assessments,
neuro-imaging, blood samples, and in some cases FDG/PIB-PETscans, CSF
biomarkers or genetic counselling were discussed.
Frontal brain injury subjects
- Patients with frontal brain injury (e.g. traumatic brain injury, stroke or
brain tumour patients).
Non-frontal brain injury subjects
- Patients with non-frontal brain injury (e.g. traumatic brain injury, stroke
or brain tumour patients).
Exclusion criteria
YOD subjects:
- Presence of premorbid severe neurological or psychiatric pathology,
non-related to dementia.
Brain injury subjects:
- Presence of serious psychiatric disorders or other neurological
comorbidities.
Healthy control subjects:
- Presence of serious psychiatric disorders
- History of neurological disorders, which may interfere with cognitive
functioning (e.g. recent concussion, previous subarachnoid or intracerebral
haemorrhage, intracranial tumours, epilepsy, ischemic stroke).
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
ClinicalTrials.gov | NCT06286293 |
CCMO | NL87304.042.24 |